Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

European Stocks Edge Higher; U.K. Outperforms on New Vaccine

Published 04/07/2021, 03:44 AM
Updated 04/07/2021, 03:45 AM
© Reuters.

© Reuters.

By Peter Nurse 

Investing.com - European stock markets edged higher Wednesday, as the global economy's outlook brightens, with the U.K. outperforming on the back of its speedy vaccination program and an endorsement of its prospects from the International Monetary Fund.

At 3:45 AM ET (0845 GMT), the DAX in Germany traded 0.2% higher, the CAC 40 in France rose 0.3% and the U.K.’s FTSE 100 gained 0.9%.

Investor sentiment has been boosted globally by continued support from central banks and an improving growth outlook.

The International Monetary Fund raised its 2021 global growth forecast late Tuesday to 6%, up from 5.5% less than three months ago, citing unprecedented public spending, primarily by the United States. It revised up its forecast for U.K. growth by 0.8 percentage point to over 5%.

The outlook for continental Europe is less impressive. Germany, the largest country in the European Union, is only seen growing 3.6% this year, according to the IMF, with its economy having faced different waves of infections and subsequent lockdowns. Additionally, there are concerns about the latest initiative by Euroskeptic Germans to stop Germany putting its financial firepower behind the EU's 750 billion-euro recovery plan.

There was some good news regarding the virus, with the U.K. to begin rolling out the Moderna (NASDAQ:MRNA) vaccine later Wednesday, around two weeks earlier than expected. This will become the third approved vaccine to be offered in Britain, and comes at an opportune time, with the European Medicines Agency likely to confirm later in the day a link between AstraZeneca's (NASDAQ:AZN) vaccine and potentially dangerous blood clotting reactions.

In corporate news, Nokia (NYSE:NOK) stock rose 0.5% after the Finnish telecoms company settled a multi-year patent fight with China's Lenovo Group (OTC:LNVGY), the world's biggest PC maker. 

Royal Dutch Shell (LON:RDSa) stock rose 1%, helped by higher crude prices, even as the oil major said it expects a hit of up to $200 million from the cold snap that disrupted the energy complex in Texas and other U.S. states in February.

Electricite de France (PA:EDF) stock soared 6.6% after Reuters reported that the French government expects to spend around 10 billion euros ($11.87 billion) to buy out minority shareholders as part of a proposed restructuring of the power group.

Deliveroo (LON:ROO) stock rose 2.2% in its first day of unrestricted trading, a few days after its disappointing float.

On the data front, eurozone final composite purchasing manager’s index data for March is scheduled for release later in the session, and should show improvement.

Oil prices edged higher Wednesday, helped by the stronger IMF growth forecast as well as U.S. crude inventories falling last week.

Data from the industry body, the American Petroleum Institute, showed a reduction of 2.6 million barrels for the week ending April 2, more than expected and indicative of a pickup in demand in the United States, the world's biggest fuel consumer. 

Crude oil supply data from the U.S. Energy Information Administration is due later in the day.

U.S. crude futures traded 0.3% higher at $59.48 a barrel, while the Brent contract rose 0.2% to $62.89. 

Elsewhere, gold futures fell 0.1% to $1,740.85/oz, while EUR/USD traded flat at 1.1875.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.